DrugPatentWatch Database Preview
TRELEGY ELLIPTA Drug Profile
When do Trelegy Ellipta patents expire, and when can generic versions of Trelegy Ellipta launch?
Trelegy Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. There are nineteen patents protecting this drug.
This drug has four hundred and sixty-seven patent family members in forty-eight countries.
The generic ingredient in TRELEGY ELLIPTA is fluticasone furoate; umeclidinium bromide; vilanterol trifenatate. There are twenty-nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the fluticasone furoate; umeclidinium bromide; vilanterol trifenatate profile page.
Summary for TRELEGY ELLIPTA
| International Patents: | 467 |
| US Patents: | 19 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 1 |
| Clinical Trials: | 1 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for TRELEGY ELLIPTA |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for TRELEGY ELLIPTA |
| Prior Art and Litigation Support | Order Prior Art and Litigation support for TRELEGY ELLIPTA |
| DailyMed Link: | TRELEGY ELLIPTA at DailyMed |
Generic Entry Opportunity Date for TRELEGY ELLIPTA
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Synonyms for TRELEGY ELLIPTA
| FF/UMEC/VI |
| Fluticasone furoate mixture with umeclidinium and vilanterol |
| Fluticasone furoate, umeclidinium and vilanterol |
| S900007500 |
US Patents and Regulatory Information for TRELEGY ELLIPTA
International Patents for TRELEGY ELLIPTA
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2005527496 | ➤ Sign Up |
| Portugal | 1425001 | ➤ Sign Up |
| Poland | 359999 | ➤ Sign Up |
| Costa Rica | 20120265 | ➤ Sign Up |
| Norway | 342119 | ➤ Sign Up |
| Denmark | 1960021 | ➤ Sign Up |
| United Kingdom | 0019172 | ➤ Sign Up |
| Country | Patent Number | Estimated Expiration |
Supplementary Protection Certificates for TRELEGY ELLIPTA
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1740177 | 208 50012-2014 | Slovakia | ➤ Sign Up | PRODUCT NAME: UMEKLIDINIUMBROMID; REGISTRATION NO/DATE: EU/1/14/922/001 - EU/1/14/922/003 20140430 |
| 1425001 | C300664 | Netherlands | ➤ Sign Up | PRODUCT NAME: VILANTEROL, DAN WEL EEN ZOUT OF SOLVAAT DAARVAN, IN HET BIJZONDER HET TRIFENYLACETAATZOUT; REGISTRATION NO/DATE: EU/1/13/886/001-006 20131113 |
| 1425001 | CR 2014 00021 | Denmark | ➤ Sign Up | PRODUCT NAME: VILANTEROL ELLER ET SALT ELLER SOLVAT DERAF, HERUNDER VILANTEROL TRIFENATAT; REG. NO/DATE: EU/1/13/886/001-006 20131114 |
| 1740177 | 2014/057 | Ireland | ➤ Sign Up | PRODUCT NAME: UMECLIDINIUM BROMIDE; REGISTRATION NO/DATE: EU/1/14/922/001-003 20140428 |
| 1740177 | PA2014038,C1740177 | Lithuania | ➤ Sign Up | PRODUCT NAME: UMEKLIDINO BROMIDAS; REGISTRATION NO/DATE: EU/1/14/922 20140428 |
| 1740177 | PA2014038 | Lithuania | ➤ Sign Up | PRODUCT NAME: UMECLIDINIUM BROMIDIUM; REGISTRATION NO/DATE: EU/1/14/922 20140428 |
| 1305329 | 326 | Finland | ➤ Sign Up | |
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
